Patient tagging device for reducing medical errors gets US nod
This article was originally published in Clinica
Executive Summary
The FDA has cleared for sale in the US a noninvasive tagging system aimed at safeguarding against surgical mishaps. The skin-mounted adhesive, called SurgiChip, is expected to remove the risk of patients being given the wrong surgical procedure or treated at the wrong site of injury. The product's Palm Beach Gardens, Florida based developer, also known as SurgiChip, says the product is the first external surgical marker to implement radiofrequency identification (RFID) technology.
You may also be interested in...
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.